Perdagangan Indivior PLC - INDV CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.0755 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.022491% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | 0.000573% | ||||||||
Waktu biaya inap | 21:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 0.1 | ||||||||
Mata uang | GBP | ||||||||
Margin | 20% | ||||||||
Bursa efek | United Kingdom of Great Britain and Northern Ireland | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Indivior PLC ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Key Stats
Prev. Close* | 13.658 |
Open* | 13.777 |
1-Year Change* | 396.74% |
Day's Range* | 13.727 - 13.9175 |
52 wk Range | 13.30-20.20 |
Average Volume (10 days) | 417.67K |
Average Volume (3 months) | 10.13M |
Market Cap | 1.90B |
P/E Ratio | -100.00K |
Shares Outstanding | 136.32M |
Revenue | 731.37M |
EPS | -0.38 |
Dividend (Yield %) | N/A |
Beta | -0.19 |
Next Earnings Date | Jul 26, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 31, 2023 | 13.7875 | 0.1350 | 0.99% | 13.6525 | 13.9375 | 13.6025 |
Mar 30, 2023 | 13.6580 | 0.0505 | 0.37% | 13.6075 | 13.8070 | 13.6025 |
Mar 29, 2023 | 13.6080 | 0.0405 | 0.30% | 13.5675 | 13.7175 | 13.5125 |
Mar 28, 2023 | 13.5875 | -0.2295 | -1.66% | 13.8170 | 14.0870 | 13.5725 |
Mar 27, 2023 | 13.8075 | 0.0400 | 0.29% | 13.7675 | 14.0865 | 13.7620 |
Mar 24, 2023 | 13.8620 | -0.2945 | -2.08% | 14.1565 | 14.1565 | 13.7275 |
Mar 23, 2023 | 14.1570 | 0.1355 | 0.97% | 14.0215 | 14.2270 | 13.9375 |
Mar 22, 2023 | 14.0265 | 0.0395 | 0.28% | 13.9870 | 14.0965 | 13.9120 |
Mar 21, 2023 | 14.0865 | 0.3145 | 2.28% | 13.7720 | 14.1070 | 13.7720 |
Mar 20, 2023 | 13.7875 | 0.2150 | 1.58% | 13.5725 | 13.8775 | 13.2685 |
Mar 17, 2023 | 13.7025 | -0.1945 | -1.40% | 13.8970 | 14.1270 | 13.6725 |
Mar 16, 2023 | 13.8670 | 0.0500 | 0.36% | 13.8170 | 14.0270 | 13.7120 |
Mar 15, 2023 | 13.8120 | -0.3895 | -2.74% | 14.2015 | 14.3270 | 13.7820 |
Mar 14, 2023 | 14.2070 | -0.1195 | -0.83% | 14.3265 | 14.3665 | 13.9720 |
Mar 13, 2023 | 14.3465 | -0.4990 | -3.36% | 14.8455 | 14.9260 | 14.2870 |
Mar 10, 2023 | 14.7560 | -0.1095 | -0.74% | 14.8655 | 15.0050 | 14.6110 |
Mar 9, 2023 | 14.9900 | -0.0550 | -0.37% | 15.0450 | 15.2555 | 14.9305 |
Mar 8, 2023 | 15.0450 | 0.0495 | 0.33% | 14.9955 | 15.1155 | 14.8505 |
Mar 7, 2023 | 15.1155 | -0.0700 | -0.46% | 15.1855 | 15.2155 | 15.0255 |
Mar 6, 2023 | 15.2055 | 0.1255 | 0.83% | 15.0800 | 15.2055 | 14.9005 |
Indivior PLC Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 901 | 791 | 647 | 785 | 1005 |
Revenue | 901 | 791 | 647 | 785 | 1005 |
Cost of Revenue, Total | 159 | 127 | 92 | 140 | 128 |
Gross Profit | 742 | 664 | 555 | 645 | 877 |
Total Operating Expense | 986 | 587 | 810 | 609 | 713 |
Selling/General/Admin. Expenses, Total | 1065 | 393 | 410 | 371 | 465 |
Research & Development | 72 | 52 | 40 | 53 | 67 |
Depreciation / Amortization | 13 | 17 | 19 | 13 | |
Operating Income | -85 | 204 | -163 | 176 | 292 |
Interest Income (Expense), Net Non-Operating | -10 | -14 | -8 | 4 | -14 |
Net Income Before Taxes | -95 | 190 | -173 | 180 | 278 |
Net Income After Taxes | -53 | 205 | -148 | 134 | 273 |
Net Income Before Extra. Items | -53 | 205 | -148 | 134 | 273 |
Net Income | -53 | 205 | -148 | 134 | 275 |
Income Available to Common Excl. Extra. Items | -53 | 205 | -148 | 134 | 273 |
Income Available to Common Incl. Extra. Items | -53 | 205 | -148 | 134 | 275 |
Diluted Net Income | -53 | 205 | -148 | 134 | 275 |
Diluted Weighted Average Shares | 139.012 | 154.228 | 146.573 | 151.072 | 150.228 |
Diluted EPS Excluding Extraordinary Items | -0.38126 | 1.3292 | -1.00974 | 0.887 | 1.81723 |
Dividends per Share - Common Stock Primary Issue | |||||
Diluted Normalized EPS | -2.01421 | 1.60152 | 0.95516 | 1.01276 | 2.36973 |
Unusual Expense (Income) | -302 | 2 | 251 | 26 | 40 |
Total Extraordinary Items | 0 | 2 | |||
Dilution Adjustment | 0 | ||||
Other, Net | -2 | ||||
Other Operating Expenses, Total | -8 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Total revenue | 241 | 232 | 221 | 207 | 223 |
Revenue | 241 | 232 | 221 | 207 | 223 |
Cost of Revenue, Total | 43 | 40 | 38 | 37 | 39 |
Gross Profit | 198 | 192 | 183 | 170 | 184 |
Total Operating Expense | 499 | 176 | 158 | 153 | 178 |
Selling/General/Admin. Expenses, Total | 729 | 117 | 106 | 106 | 137 |
Research & Development | 29 | 20 | 14 | 8 | 19 |
Depreciation / Amortization | 3 | 3 | 3 | ||
Unusual Expense (Income) | -303 | -2 | -5 | -1 | -20 |
Operating Income | -258 | 56 | 63 | 54 | 45 |
Interest Income (Expense), Net Non-Operating | 2 | -2 | -5 | -6 | -5 |
Net Income Before Taxes | -256 | 54 | 58 | 48 | 40 |
Net Income After Taxes | -183 | 41 | 48 | 41 | 36 |
Net Income Before Extra. Items | -183 | 41 | 48 | 41 | 36 |
Net Income | -183 | 41 | 48 | 41 | 36 |
Income Available to Common Excl. Extra. Items | -183 | 41 | 48 | 41 | 36 |
Income Available to Common Incl. Extra. Items | -183 | 41 | 48 | 41 | 36 |
Diluted Net Income | -183 | 41 | 48 | 41 | 36 |
Diluted Weighted Average Shares | 136.784 | 146.628 | 146.809 | 149.005 | 150.638 |
Diluted EPS Excluding Extraordinary Items | -1.33788 | 0.27962 | 0.32695 | 0.27516 | 0.23898 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Diluted Normalized EPS | -2.99743 | 0.26598 | 0.2929 | 0.26845 | 0.0863 |
Other Operating Expenses, Total | 1 | 1 | 2 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Current Assets | 1444 | 1187 | 1360 | 1329 | 1225 |
Cash and Short Term Investments | 1102 | 858 | 1060 | 924 | 863 |
Cash & Equivalents | 1102 | 858 | 1060 | 924 | 863 |
Total Receivables, Net | 215 | 186 | 204 | 318 | 295 |
Accounts Receivable - Trade, Net | 202 | 179 | 192 | 269 | 257 |
Total Inventory | 95 | 93 | 73 | 78 | 52 |
Prepaid Expenses | 18 | 17 | 23 | 9 | 15 |
Total Assets | 1832 | 1531 | 1652 | 1547 | 1444 |
Property/Plant/Equipment, Total - Net | 95 | 103 | 107 | 57 | 54 |
Property/Plant/Equipment, Total - Gross | 169 | 171 | 175 | 109 | 101 |
Accumulated Depreciation, Total | -74 | -68 | -68 | -52 | -47 |
Intangibles, Net | 82 | 62 | 72 | 84 | 92 |
Other Long Term Assets, Total | 127 | 97 | 63 | 44 | 58 |
Total Current Liabilities | 804 | 599 | 742 | 818 | 854 |
Accounts Payable | 137 | 20 | 39 | 47 | 40 |
Accrued Expenses | 583 | 504 | 584 | 674 | 625 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 11 | 12 | 9 | 4 | 5 |
Other Current Liabilities, Total | 73 | 63 | 110 | 93 | 184 |
Total Liabilities | 1629 | 1449 | 1443 | 1481 | 1647 |
Total Long Term Debt | 275 | 273 | 284 | 237 | 477 |
Long Term Debt | 239 | 230 | 233 | 237 | 477 |
Other Liabilities, Total | 550 | 577 | 417 | 426 | 316 |
Total Equity | 203 | 82 | 209 | 66 | -203 |
Common Stock | 70 | 73 | 73 | 73 | 72 |
Retained Earnings (Accumulated Deficit) | 146 | 16 | 154 | 20 | -263 |
Other Equity, Total | -20 | -13 | -23 | -32 | -14 |
Total Liabilities & Shareholders’ Equity | 1832 | 1531 | 1652 | 1547 | 1444 |
Total Common Shares Outstanding | 702.44 | 733.635 | 730.788 | 728.442 | 721.463 |
Note Receivable - Long Term | 84 | 82 | 50 | 33 | 15 |
Additional Paid-In Capital | 7 | 6 | 5 | 5 | 2 |
Capital Lease Obligations | 36 | 43 | 51 | ||
Other Current Assets, Total | 14 | 33 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 1263 | 1444 | 1314 | 1292 | 1267 |
Cash and Short Term Investments | 939 | 1102 | 1005 | 1000 | 945 |
Cash & Equivalents | 874 | 1102 | 1005 | 1000 | 945 |
Total Receivables, Net | 208 | 215 | 175 | 178 | 208 |
Accounts Receivable - Trade, Net | 195 | 202 | 175 | 170 | 165 |
Total Inventory | 91 | 95 | 97 | 93 | 91 |
Other Current Assets, Total | 10 | 32 | 37 | 21 | 23 |
Total Assets | 1724 | 1832 | 1700 | 1671 | 1611 |
Property/Plant/Equipment, Total - Net | 90 | 95 | 95 | 99 | 100 |
Intangibles, Net | 78 | 82 | 84 | 88 | 60 |
Note Receivable - Long Term | 82 | 84 | 82 | 82 | 82 |
Other Long Term Assets, Total | 126 | 127 | 125 | 110 | 102 |
Total Current Liabilities | 728 | 804 | 712 | 633 | 656 |
Accounts Payable | 64 | 137 | 33 | 27 | 25 |
Accrued Expenses | 579 | 583 | 517 | 500 | 504 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 11 | 11 | 11 | 11 | 12 |
Other Current Liabilities, Total | 74 | 73 | 151 | 95 | 115 |
Total Liabilities | 1492 | 1629 | 1539 | 1438 | 1447 |
Total Long Term Debt | 271 | 275 | 277 | 279 | 270 |
Long Term Debt | 238 | 239 | 239 | 239 | 229 |
Capital Lease Obligations | 33 | 36 | 38 | 40 | 41 |
Other Liabilities, Total | 493 | 550 | 550 | 526 | 521 |
Total Equity | 232 | 203 | 161 | 233 | 164 |
Common Stock | 71 | 70 | 72 | 73 | 73 |
Additional Paid-In Capital | 7 | 7 | 7 | 6 | 6 |
Retained Earnings (Accumulated Deficit) | 180 | 146 | 101 | 165 | 97 |
Other Equity, Total | -26 | -20 | -19 | -11 | -12 |
Total Liabilities & Shareholders’ Equity | 1724 | 1832 | 1700 | 1671 | 1611 |
Total Common Shares Outstanding | 706.024 | 702.44 | 733.505 | 734.839 | 732.408 |
Short Term Investments | 65 | ||||
Prepaid Expenses | 15 | ||||
Long Term Investments | 85 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net income/Starting Line | 213 | -156 | 178 | 292 | 193 |
Cash From Operating Activities | 353 | -193 | 151 | 303 | 295 |
Cash From Operating Activities | 22 | 26 | 28 | 40 | 13 |
Non-Cash Items | -21 | 1 | 1 | -34 | 22 |
Cash Taxes Paid | 17 | 34 | -18 | 16 | 33 |
Cash Interest Paid | 18 | 20 | 17 | 25 | 36 |
Changes in Working Capital | 139 | -64 | -56 | 5 | 67 |
Cash From Investing Activities | -14 | -4 | -2 | -4 | -43 |
Capital Expenditures | -34 | -4 | -7 | -41 | -43 |
Cash From Financing Activities | -94 | -10 | -13 | -237 | -84 |
Total Cash Dividends Paid | 0 | ||||
Issuance (Retirement) of Debt, Net | 6 | -11 | -13 | -240 | -86 |
Foreign Exchange Effects | -1 | 5 | 0 | -1 | 3 |
Net Change in Cash | 244 | -202 | 136 | 61 | 171 |
Issuance (Retirement) of Stock, Net | -100 | 1 | 0 | 3 | 2 |
Other Investing Cash Flow Items, Total | 20 | 0 | 5 | 37 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 54 | 213 | 168 | 130 | 57 |
Cash From Operating Activities | -75 | 353 | 186 | 160 | 89 |
Cash From Operating Activities | 5 | 22 | 18 | 12 | 5 |
Non-Cash Items | -8 | -21 | -24 | -8 | -1 |
Cash Taxes Paid | 2 | 17 | -7 | -17 | 2 |
Cash Interest Paid | 9 | 18 | 14 | 10 | 4 |
Changes in Working Capital | -126 | 139 | 24 | 26 | 28 |
Cash From Investing Activities | -149 | -14 | -12 | -30 | 1 |
Other Investing Cash Flow Items, Total | -149 | 20 | 20 | 1 | 1 |
Cash From Financing Activities | -2 | -94 | -26 | 11 | -3 |
Issuance (Retirement) of Stock, Net | 1 | -100 | -34 | 0 | 0 |
Issuance (Retirement) of Debt, Net | -3 | 6 | 8 | 11 | -3 |
Net Change in Cash | -228 | 244 | 149 | 142 | 87 |
Capital Expenditures | -34 | -32 | -31 | ||
Foreign Exchange Effects | -2 | -1 | 1 | 1 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Scopia Capital Management LP | Hedge Fund | 8.9993 | 12267363 | -1296708 | 2022-12-22 | MED |
Kairos Capital Management, LLC | Investment Advisor | 5.5106 | 7511808 | 0 | 2022-03-17 | LOW |
Société Générale Securities Services S.A. | Research Firm | 4.8777 | 6649013 | -400203 | 2023-01-18 | LOW |
Morgan Stanley & Co. International Plc | Research Firm | 4.1855 | 5705504 | 744713 | 2023-03-01 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.9471 | 4017387 | 179724 | 2022-11-30 | LOW |
Artemis Investment Management LLP | Investment Advisor/Hedge Fund | 2.2667 | 3089916 | -847315 | 2022-11-26 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 2.098 | 2859915 | 0 | 2023-02-01 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.0154 | 2747324 | -2666 | 2023-02-01 | LOW |
Capital Research Global Investors | Investment Advisor | 1.8464 | 2516920 | 155800 | 2022-11-30 | LOW |
Liontrust Investment Partners LLP | Investment Advisor | 1.6467 | 2244725 | -222701 | 2022-11-30 | LOW |
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 1.5219 | 2074519 | 0 | 2023-02-01 | LOW |
Prelude Capital Management, LLC | Hedge Fund | 1.3416 | 1828853 | 0 | 2022-11-24 | HIGH |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.2975 | 1768698 | 1572 | 2022-11-30 | LOW |
Newtyn Management, LLC | Hedge Fund | 1.1407 | 1555000 | 0 | 2022-10-31 | MED |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.9342 | 1273429 | -9410 | 2023-02-01 | LOW |
Jupiter Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.9053 | 1234022 | -581502 | 2022-11-26 | LOW |
Two Seas Capital LP | Hedge Fund | 0.8328 | 1135195 | 167039 | 2022-10-31 | MED |
Premier Asset Management Ltd | Investment Advisor/Hedge Fund | 0.7581 | 1033439 | -657653 | 2022-11-26 | LOW |
State Street Global Advisors (UK) Ltd. | Investment Advisor/Hedge Fund | 0.6466 | 881428 | -3729 | 2022-11-30 | LOW |
Amati Global Investors Limited | Investment Advisor | 0.6137 | 836499 | -786451 | 2022-11-26 | LOW |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group500K+
Trader
92K+
Klien aktif per bulan
$53M+
Volume investasi per bulan
$30M+
Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Proprietary & Advanced Pharmaceuticals |
234 Bath Road
SL1 4EE
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com